Skip to main content

Table 1 Newcastle–Ottawa scale (prospective study)

From: Malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in ischemic stroke: a systematic review

No.

First author, year

Selection

Comparability

Outcome

Total

1

2

3

4

1

2

3

1.

Atiba, 2020 [28]

 

*

*

*

**

*

*

*

9

2.

Aygul, Turkey, 2008 [29]

 

*

*

*

**

*

*

*

8

3.

Cano, 2003 [30]

 

*

*

*

**

*

*

*

8

4.

Cojocaru, 2013 [31]

 

*

*

*

**

*

*

*

8

5.

Dominguez, 2010 [32]

 

*

*

*

 

*

*

*

6

6.

Elsayed, 2020 [18]

 

*

*

*

 

*

*

*

7

7.

Liu, 2017 [17]

*

*

*

*

*

*

*

*

8

8.

Liu, 2018 [11]

 

*

*

*

**

*

*

*

9

9.

Lorente, Spain, 2015 [33]

 

*

*

*

**

*

*

*

8

10.

Lorente, Spain, 2016 [34]

 

*

*

*

**

*

*

*

8

11.

Lorente, 2021 [35]

 

*

*

*

**

*

*

*

9

12.

Lorenzano, 2018 [36]

*

*

*

*

**

*

*

*

9

13.

Mizukoshi, 2005 [37]

  

*

*

 

*

*

*

5

14.

Nakajima, 2012 [12]

  

*

*

 

*

*

*

5

15.

Polidori, 2002 [38]

 

*

*

*

**

*

*

*

8

16.

Tsai, 2014 [39]

 

*

*

*

**

*

*

*

8

17.

Zimmermann, 2004 [40]

 

*

*

*

**

*

*

*

8

  1. Maximum point for comparability was 2
  2. Selection: (1) representativeness, (2) selection of non-exposed, (3) ascertainment of exposure, (4) demonstration that outcome was not present at the beginning
  3. Outcome: (1) assessment of the outcome, (2) follow-up long enough, (3) adequacy of follow-up
  4. The sign of * meant the point that each article was got